Showing 1 - 7 results of 7 for search 'Leila Cochón', query time: 0.04s Refine Results
  1. 1
    A randomized crossover study to evaluate local tolerability following subcutaneous administration of a new depot medroxyprogesterone acetate contraceptive formulation

    A randomized crossover study to evaluate local tolerability following subcutaneous administration of a new depot medroxyprogesterone acetate contraceptive formulation by Vera Halpern, Angie Wheeless, Vivian Brache, Anja Lendvay, Leila Cochón, Douglas Taylor, Laneta J. Dorflinger

    Published 2023-01-01
    Get full text
    Article
  2. 2
    New approaches for developing biomarkers of hormonal contraceptive use

    New approaches for developing biomarkers of hormonal contraceptive use by Rakhee Sachdeva, Narender Kumar, Vivian Brache, Barbara A. Friedland, Marlena Plagianos, Shimin Zhang, Larisa Kizima, Leila Cochon, Ana Sofía Tejada Tabar, Ann Blanc, Ruth B. Merkatz

    Published 2023-01-01
    Get full text
    Article
  3. 3
    Randomized, placebo controlled phase I trial of the safety, pharmacokinetics, pharmacodynamics and acceptability of a 90 day tenofovir plus levonorgestrel vaginal ring used continuously or cyclically in women: The CONRAD 138 study.

    Randomized, placebo controlled phase I trial of the safety, pharmacokinetics, pharmacodynamics and acceptability of a 90 day tenofovir plus levonorgestrel vaginal ring used continu... by Andrea R Thurman, Vivian Brache, Leila Cochon, Louise A Ouattara, Neelima Chandra, Terry Jacot, Nazita Yousefieh, Meredith R Clark, Melissa Peet, Homaira Hanif, Jill L Schwartz, Susan Ju, Mark A Marzinke, David W Erikson, Urvi Parikh, Betsy C Herold, Raina N Fichorova, Elizabeth Tolley, Gustavo F Doncel

    Published 2022-01-01
    Get full text
    Article
  4. 4
    Safety and Pharmacokinetics of a Tenofovir Alafenamide Fumarate-Emtricitabine based Oral Antiretroviral Regimen for Prevention of HIV Acquisition in Women: A Randomized Controlled Trial

    Safety and Pharmacokinetics of a Tenofovir Alafenamide Fumarate-Emtricitabine based Oral Antiretroviral Regimen for Prevention of HIV Acquisition in Women: A Randomized Controlled... by Andrea R. Thurman, MD, Jill L. Schwartz, MD, Mackenzie L. Cottrell, PharmD, Vivian Brache, Lic, Beatrice A. Chen, MD, MPH, Leila Cochón, Lic, Susan Ju, BA, Ian McGowan, MD PhD, James F. Rooney, MD, Scott McCallister, MD, Gustavo F. Doncel, MD PhD

    Published 2021-06-01
    Get full text
    Article
  5. 5
    Randomized, placebo controlled phase I trial of the safety, pharmacokinetics, pharmacodynamics and acceptability of a 90 day tenofovir plus levonorgestrel vaginal ring used continuously or cyclically in women: The CONRAD 138 study

    Randomized, placebo controlled phase I trial of the safety, pharmacokinetics, pharmacodynamics and acceptability of a 90 day tenofovir plus levonorgestrel vaginal ring used continu... by Andrea R. Thurman, Vivian Brache, Leila Cochon, Louise A. Ouattara, Neelima Chandra, Terry Jacot, Nazita Yousefieh, Meredith R. Clark, Melissa Peet, Homaira Hanif, Jill L. Schwartz, Susan Ju, Mark A. Marzinke, David W. Erikson, Urvi Parikh, Betsy C. Herold, Raina N. Fichorova, Elizabeth Tolley, Gustavo F. Doncel

    Published 2022-01-01
    Get full text
    Article
  6. 6
    No evidence of fetal defects or anti-syncytin-1 antibody induction following COVID-19 mRNA vaccination.

    No evidence of fetal defects or anti-syncytin-1 antibody induction following COVID-19 mRNA vaccination. by Alice Lu-Culligan, Alexandra Tabachnikova, Eddy Pérez-Then, Maria Tokuyama, Hannah J Lee, Carolina Lucas, Valter Silva Monteiro, Marija Miric, Vivian Brache, Leila Cochon, M Catherine Muenker, Subhasis Mohanty, Jiefang Huang, Insoo Kang, Charles Dela Cruz, Shelli Farhadian, Melissa Campbell, Inci Yildirim, Albert C Shaw, Shuangge Ma, Sten H Vermund, Albert I Ko, Saad B Omer, Akiko Iwasaki

    Published 2022-05-01
    Get full text
    Article
  7. 7
    No evidence of fetal defects or anti-syncytin-1 antibody induction following COVID-19 mRNA vaccination

    No evidence of fetal defects or anti-syncytin-1 antibody induction following COVID-19 mRNA vaccination by Alice Lu-Culligan, Alexandra Tabachnikova, Eddy Pérez-Then, Maria Tokuyama, Hannah J. Lee, Carolina Lucas, Valter Silva Monteiro, Marija Miric, Vivian Brache, Leila Cochon, M. Catherine Muenker, Subhasis Mohanty, Jiefang Huang, Insoo Kang, Charles Dela Cruz, Shelli Farhadian, Melissa Campbell, Inci Yildirim, Albert C. Shaw, Shuangge Ma, Sten H. Vermund, Albert I. Ko, Saad B. Omer, Akiko Iwasaki

    Published 2022-05-01
    Get full text
    Article

Search Tools: